Doses of folic acid greater than 0.1 mg per day may result in hematologic remission in patients with vitamin B 12deficiency
On the data side, the Lau phase 2 obesity trial showed Cagrilintide monotherapy producing dose-related weight loss, reaching close to 10.8 percent at the top dose over roughly 26 weeks, against about 3 percent on placebo
Semaglutide's STEP 1 trial (1,961 subjects, 68 weeks) demonstrated 14.9% mean weight loss
(2018) demonstrated that the individual diagnostic performance of HGF was inadequate
Healthcare providers play an important role in ensuring safe medication administration by implementing the following best practices: When an intramuscular injection is administered incorrectly, it can cause immediate or delayed complications
Learn the bidirectional relationship between sex hormones and mental health and how hormone optimization can be a powerful treatment tool